BioSpace News Archive

Drug Development

Nektar Therapeutics Announces Initiation of First-in-Human Phase 1 Clinical Study of NKTR-255, an IL-15 Agonist, in Adults with Relapsed or Refractory Non-Hodgkin Lymphoma or Multiple Myeloma

Nektar Therapeutics (NASDAQ: NKTR) today announced the initiation of a first-in-human, Phase 1 clinical study evaluating NKTR-255, an interleukin-15 (IL-15) receptor agonist, as monotherapy for patients with relapsed or refractory non-Hodgkin lymphoma (NHL) or multiple myeloma (MM).

October 16, 2019
·
7 min read
Business

Masimo to Report Third Quarter 2019 Financial Results after Market Close on Wednesday, October 30

Masimo (NASDAQ: MASI) announced today that it will release third quarter 2019 financial results for the period ended September 28, 2019, after the market closes on Wednesday, October 30, 2019

October 16, 2019
·
5 min read
Business

ACADIA Pharmaceuticals to Announce Third Quarter 2019 Financial Results on October 30, 2019

ACADIA to Host Conference Call and Webcast on Wednesday, October 30, 2019, at 4:30 p.m. Eastern Time

October 16, 2019
·
3 min read
Biotech Beach

XIFIN Ranks No. 1 for Outsourced Laboratory Support & RCM in Black Book Research Survey

As value-based care initiatives and reform continue to put pressure on hospitals to decrease inpatient volumes, achieve outcomes goals and provide cost-effective care, clinical services outsourcing is becoming a necessity

October 16, 2019
·
4 min read
Pharm Country

Oligomerix, Inc. to Present Data on Lead Alzheimer’s Disease Candidate at Neuroscience 2019

Compound is an oral small molecule inhibitor of tau aggregation

October 16, 2019
·
2 min read
Deals

Thrive Global Acquires Boundless Mind, Neuroscience-based Artificial Intelligence Company to Power Health and Productivity Behavior Change

Thrive Global, the leading behavior change technology company founded by Arianna Huffington in November 2016, announced today the acquisition of Boundless Mind, the neuroscience-based artificial intelligence company and leader in behavioral design and engineering.

October 16, 2019
·
6 min read
Business

MC10, Inc. Announces Collaboration with Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago: Innovating Precision Medicine Approaches to Improve Maternal-Infant Outcomes

This collaboration bridges MC10’s expertise in wearable health solutions, DevSci’s leading-edge research on how the prenatal environment shapes early brain and behavioral development, and Lurie Children’s expertise in research at the maternal-fetal interface.

October 16, 2019
·
5 min read
Pharm Country

Flatiron Health Announces Clinical Decision Support Application Through Epic’s App Orchard

Flatiron Assist™ to Integrate Clinical Decision Support Tools Within Oncology Workflows

October 16, 2019
·
3 min read
Drug Development

Amphivena Initiates Solid Tumor Clinical Trial

Amphivena to advance AMV564 in a Multi-Center Dose Finding Phase 1 Clinical Study in Patients with Solid Tumors

October 16, 2019
·
3 min read
Business

Enzyvant Appoints Jeb Ledell as Chief Operating Officer

Former COO of Compass and Horizon Discovery joins Enzyvant as company nears first potential drug approval

October 16, 2019
·
2 min read